Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
ebi-a-GCST011750 | 2016 | Response to lithium treatment in bipolar disorder (continuous phenotype) | NA | 194 | 7,390,894 |
ebi-a-GCST90014052 | 2021 | Severe COVID-19 infection | NA | 203 | 5,040,350 |
ebi-a-GCST006347 | 2018 | Anti-herpes simplex virus 2 IgG levels | NA | 208 | 5,278,042 |
ebi-a-GCST90011778 | 2021 | Etoposide drug response (IC50) | NA | 255 | 3,788,671 |
ebi-a-GCST90011777 | 2021 | Daunorubicin drug response (IC50) | NA | 259 | 3,788,733 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: